Report for: Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension

Title	Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension
Published in	Cochrane database of systematic reviews, January 2010
DOI	10.1002/14651858.cd007185.pub2
Pubmed ID	20091622
Authors	Jenny MH Chen, Balraj S Heran, Marco I Perez, James M Wright
Abstract	Beta-blockers are one of the more commonly prescribed classes of anti-hypertensive drugs, both as first-line and second-line.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
Spain	1	33%
Unknown	2	67%

Demographic breakdown

Type	Count	As %
Members of the public	3	100%

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
Japan	1	1%
United Kingdom	1	1%
Colombia	1	1%
Unknown	89	97%

Demographic breakdown

Readers by professional status	Count	As %
Student > Master	12	13%
Student > Bachelor	12	13%
Researcher	10	11%
Student > Ph. D. Student	8	9%
Student > Postgraduate	6	7%
Other	18	20%
Unknown	26	28%

Readers by discipline	Count	As %
Medicine and Dentistry	42	46%
Nursing and Health Professions	6	7%
Biochemistry, Genetics and Molecular Biology	4	4%
Agricultural and Biological Sciences	4	4%
Pharmacology, Toxicology and Pharmaceutical Science	2	2%
Other	5	5%
Unknown	29	32%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2020.

All research outputs

#6,392,102

of 23,577,761 outputs

Outputs from Cochrane database of systematic reviews

#8,269

of 12,746 outputs

Outputs of similar age

#40,945

of 167,209 outputs

Outputs of similar age from Cochrane database of systematic reviews

#59

of 120 outputs

Altmetric has tracked 23,577,761 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.

So far Altmetric has tracked 12,746 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.1. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,209 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.

We're also able to compare this research output to 120 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.

Cochrane Database of Systematic Reviews

Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context